You are using an outdated browser. Please upgrade your browser to improve your experience.
iPlexus Dashboard

iPlexus Medical Affairs is a dashboard giving its users an at a glance information on the clinical trials status for all the interventions of user’s interest

iPlexus Medical Affairs is a dashboard giving its users an at a glance information on the clinical trials status for all the interventions of user’s interest

iPlexus Dashboard

by Innoplexus Consulting Services Private Limited
iPlexus Dashboard
iPlexus Dashboard
iPlexus Dashboard

What is it about?

iPlexus Medical Affairs is a dashboard giving its users an at a glance information on the clinical trials status for all the interventions of user’s interest. The present dashboard discusses about the considerably top 10 interventions under clinical trials which can treat ‘Multiple Sclerosis’. As the users of this dashboard are mainly understood to be Medical Affairs personnel, it provides a gist to them on the clinical trials, disease and drug guidelines, and the label revisions of the drugs

iPlexus Dashboard

App Details

Version
1.8
Rating
NA
Size
50Mb
Genre
Medical Productivity
Last updated
August 18, 2018
Release date
August 29, 2017
More info

App Screenshots

iPlexus Dashboard screenshot-0
iPlexus Dashboard screenshot-1
iPlexus Dashboard screenshot-2
iPlexus Dashboard screenshot-3
iPlexus Dashboard screenshot-4

App Store Description

iPlexus Medical Affairs is a dashboard giving its users an at a glance information on the clinical trials status for all the interventions of user’s interest. The present dashboard discusses about the considerably top 10 interventions under clinical trials which can treat ‘Multiple Sclerosis’. As the users of this dashboard are mainly understood to be Medical Affairs personnel, it provides a gist to them on the clinical trials, disease and drug guidelines, and the label revisions of the drugs

iPlexus Regulatory Affairs is a dashboard giving its users an at a glance information on the latest regulatory updates of major regulatory boards, disease and drug guidelines, and drug launches across regulatory bodies. The present dashboard discusses about the indication ‘Multiple Sclerosis’ and the related latest regulatory updates. As the users of this dashboard are mainly understood to be Regulatory Affairs personnel to develop and execute regulatory strategy to ensure the collective efforts of the drug development team results in a product is approvable by global regulators but is also different from the competitors’ market in a way. The information on our dashboard will help the regulatory affairs personnel to get all the information at one stop while the data is curated, analysed and made visually appealing.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.